Appropriate screening interval to detect the development of chronic metabolic diseases-Reference-Cited by-同舟云学术

Appropriate screening interval to detect the development of chronic metabolic diseases

Published:2023-05 Issue: Volume:199 Page:110648
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Sung Ki-Chul,Kyung Yoo Tae,Yeon Lee Mi,Paul Lock John

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference33 articles.

1. 2016 European Guidelines on cardiovascular disease prevention in clinical practice

2. Estimation of atherosclerotic cardiovascular disease risk among patients in the veterans affairs health care system;Vassy;JAMA Netw Open,2020

3. Associations between dietary patterns and subclinical cardiac injury: an observational analysis from the DASH trial;Juraschek;Ann Intern Med,2020

4. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Arnett;Circulation,2019

5. Association between modifiable risk factors and pharmaceutical expenditures among adults with atherosclerotic cardiovascular disease in the United States: 2012–2013 medical expenditures panel survey;Salami;J Am Heart Assoc,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between epicardial adipose tissue and myocardial work by non-invasive left ventricular pressure-strain loop in people with suspected metabolic syndrome;Scientific Reports;2023-09-02